Overview

A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
A pilot study on the acceptability and feasibility with Mifepristone and 400 mg of sub-lingual Misoprostol between 71-77 and 78-84 days of gestation for 50 cases.
Phase:
Phase 4
Details
Lead Sponsor:
Gynuity Health Projects
Collaborator:
Hopital La Rabta
Treatments:
Mifepristone
Misoprostol